Jon S. Saxe's Insider Trades & SAST Disclosures
Jon S. Saxe's most recent trade in VistaGen Therapeutics Inc was a trade of 14,100 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 6, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jon S. Saxe.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | Jon S. Saxe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 14,100 | 14,100 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jon S. Saxe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jon S. Saxe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jon S. Saxe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2021 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Jon S. Saxe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.50 per share. | 19 Mar 2021 | 2,500 | 5,751 (0%) | 0% | 1.5 | 3,750 | Common Stock |
| VistaGen Therapeutics Inc | Jon S. Saxe | Director | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 21 Aug 2020 | 30,000 | 50,000 (0%) | 0% | 0.7 | 20,700 | Common Stock |
| Durect Corp | Jon S. Saxe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 55,000 | 55,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| VistaGen Therapeutics Inc | Jon S. Saxe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges